Abbreviated New Drug Application (ANDA)/505 (j) pathway
Abbreviated New Drug Application (ANDA)/505 (j) pathway
An ANDA contains data which is submitted to FDA for the review and potential approval of a generic drug product. Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, lower cost alternative to the brand-name drug it references.